Cargando…
Metabolomics and Biomarkers for Drug Discovery
Metabolomics and biomarkers are increasingly used in drug discovery and development, and are applied to personalized medicine. Progress in these research areas has increased our understanding of disease pathology and improved therapeutic strategies for many diseases with unmet challenges. Further ad...
Autor principal: | Yeung, Pollen K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876001/ https://www.ncbi.nlm.nih.gov/pubmed/29385049 http://dx.doi.org/10.3390/metabo8010011 |
Ejemplares similares
-
Post-Exercise Hypotension: An Alternative Management Strategy for Hypertension and Cardiovascular Disease?
por: Aly, Khaled, et al.
Publicado: (2023) -
Proteomics and Nucleotide Profiling as Tools for Biomarker and Drug Target Discovery
por: Honoré, Bent, et al.
Publicado: (2021) -
Functional metabolomics: from biomarker discovery to metabolome reprogramming
por: Peng, Bo, et al.
Publicado: (2015) -
Metabolomics Reveals Molecular Signatures for Psoriasis Biomarkers and Drug Targets Discovery
por: Song, Qian, et al.
Publicado: (2023) -
Metabolomics for Biomarker Discovery in Gastroenterological Cancer
por: Nishiumi, Shin, et al.
Publicado: (2014)